secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProPhase Labs, Inc. (PRPH)
CIK:        0000868278
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001493152-25-004210
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProPhase Labs enters $7.73M equity line with Keystone Capital; issues 352,176 commitment shares
--------------------------------------------------------------------------------

- Up to $7,730,973 of common stock may be sold to Keystone Capital at 90% of lowest traded price or VWAP.
- Commitment fee: 352,176 shares issued to investor as consideration for the purchase commitment.
- Use of proceeds: working capital and general corporate purposes; 30% to redeem preferred stock if issued.
- Each fixed purchase limited to lower of 100,000 shares or $100,000; VWAP purchases capped at $5M aggregate.
- Investor prohibited from short sales or hedging during term; company retains termination right upon one day notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/868278/000149315225004210/0001493152-25-004210-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/868278/000149315225004210/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-004210

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer